Future Oncology Journal Issues Research Articles in Vol. 19, No. 1
April 03, 2023
April 03, 2023
LONDON, England, April 3 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles on the following topics in its Vol. 19, No. 1 edition:
Clinical Trial Protocol:
* A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma
Drug Evaluation:
* Lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphoma
< . . .
Clinical Trial Protocol:
* A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma
Drug Evaluation:
* Lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphoma
< . . .